Teachers, bureaucrats and principals must sustain their commitment to actively contribute to the critique and reconstruction of teacher preparation, and be central to, course design and accreditation, the delivery of the course and the assessment
of impact of programs on student learning.
«I think we will see more
of an impact of those programs in the next few years as more farmers start the transition process (to organic),» says Heilman.
If you're wanting to use a STEM education program that hasn't been evaluated, Rosicka says it's important to consider how the impact on student learning will be measured and before you allocate any funding or staff time get in touch with the program provider and ask three questions: Is there existing evidence
of the impact of this program on students» learning?
Other types of prevention programs may be necessary to reduce more normative types of disruptive behavior among young adolescents.32 In light
of the impact of this program on maternal and youth crime and corresponding government expenditures, 8,33 the US Department of Justice is now supporting an effort to make this program available to a larger number of high - crime communities.34
Not exact matches
By focusing on outcomes for Canadians and making evidence - based decisions that are anchored in meaningful data and indicators, the Government is moving to a culture
of measurement and
impact, and is putting in place the tools to deliver on priorities, align resources to
programs and activities that deliver real value for Canadians, and provide meaningful information to Canadians and Parliament.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing
programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development
programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787
program; 4) margin pressures and the potential for additional forward losses on new and maturing
programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse
impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse
impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the
impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging
programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or
impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing
program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
We make the most
of available government
programs and incentives to create affordable units, even as we provide a return to our social
impact financial partners.
Part
of Sessions» argument in favor
of rescinding the
program was economic; he said it had adversely
impacted native born Americans «It also denied jobs to hundreds
of thousands
of Americans by allowing those same jobs to go to illegal aliens,» he said.
In adopting its Cannabis Equity
Program, the City
of Oakland made a clear commitment to ensure access and equity in legal cannabis for communities most negatively
impacted by the drug war.
Instead, the startup
program should be seen as just one part
of Google's emerging efforts to remake the economic
impact of patents in the tech industry.
The resulting data will help shape the details
of the
program, and «allow us to focus resources on where the greatest
impact will be,» says Bob Annibale, Global Director
of Community Development at Citigroup.
«Taking a look at a country like New Zealand — number four in the ranking — we can see the
impact of a
program they implemented 10 years ago,» says Farrington.
«There's a full section that talks about pay equity, and what is the larger
impact that the gender pay gap has on our society, our economy, our families,» says Deepti Gudipati, vice president
of member leadership
programs for the AAUW, who is working with the city to roll out the
program.
Nixon said the Germans are probably suffering from a «lack
of legitimacy» at the central bank and are still very concerned about the
impact of quantitative easing — a massive stimulus
program following the euro zone debt crisis
of 2011 that's designed to boost lending but also stoke inflation.
A team under Airbnb's global head
of social
impact, Kim Rubey, was already working on a
program to house refugee relief workers in Greece, Macedonia and Serbia, but to address the product challenge, Gebbia formed a new team under his Samara studio that was ultimately spun out and called the Human team.
Affiliate - marketing
programs can provide a substantial upside to an entrepreneur through their ability to involve a cadre
of influencers, someone who has an above - average
impact on a specific field and can sawy their social - media following.
This is just one
of the questions that legal professionals are exploring, and that will likely
impact the development
of these
programs.
The
impact of CGI America is charted over time by what they call «progress reports,» which track how talk at the meeting turns into partnerships,
programs, funding and jobs on the ground.
These forward - looking statements include, among other things, statements about full - year 2018 guidance, project milestones, increased opportunities in the market, backlog, bids and change orders outstanding, target projects and revenue opportunity pipeline, to the extent these may be viewed as indicators
of future revenues or profitability, the expected
impacts of the F2G
program and progress toward completing the proposed combination with CB&I and the anticipated benefits
of that transaction.
In fact, here are three tips to get an employee volunteer
program (EVP) off the ground, so your startup can grow its
impact right away and make a culture
of service part
of its DNA.
Of those polled, the majority — 57 % — said the
programs have a positive
impact.
In Michigan, the Michigan Pathways to Better Health (MPBH)
program, implemented by the Michigan Public Health Institute and the Michigan Department
of Community Health, is using tablet - based checklists to collect demographic information in communities with the greatest health needs and assess behavioral health, and social service factors
impacting each patient to get a fuller picture
of social determinants
of health.
By expanding the focus
of the SBIC
program, the initiative encouraged investors to look at early stage companies and
impact investing.
I've observed for some time how CEOs and other executives can't keep their cybersecurity
programs in a silo where only a certain number
of people fully understand and appreciate their
impact.
The Defense Loan and Technical Assistance (DELTA)
Program was implemented to help ease the
impact of national defense cuts on defense - dependent small businesses.
What's especially telling is that studies indicate that prior entrepreneurial experience doesn't change the positive
impacts of an accelerator
program.
Several existing federal
programs like the Community Reinvestment Act and the Small Business Investment Companies
program are supporting the growth
of impact investing funds.
The company also just announced the expansion
of Uber Movement, a
program intended to benefit urban planners and fueled by aggregated (and anonymized) Uber ride data, covering how different times and travel times can be
impacted by major events and road closures.
The good news, according to Pentagon acquisition chief Frank Kendall, is that a range
of measures put in place over the last half - decade have made a positive
impact on the Pentagon's buying power while trimming costs across a range
of major defense
programs.
In a separate TriNet survey, 76 percent
of respondents said proposed changes to that
program would have a negative
impact on their companies.
Pitino offered a statement on Tuesday, saying that «these third - party schemes, initiated by a few bad actors, operated to commit a fraud on the
impacted universities and basketball
programs, including the University
of Louisville.»
In early July, the country's tourism secretary, Enrique de la Madrid, announced the government would implement a trial security
program in Los Cabos, Cancun, and Acapulco that month, because those areas «are the destinations that concern us most at the moment because
of the
impact they have on [Mexico's] image abroad.»
The failures
of the healthcare system have wide - ranging
impacts, according to Dimon, who said the real problem with the US deficit is the «uncontrolled growth
of our entitlement
programs,» and that in turn «the core issue underpinning the entitlements problem is healthcare in the United States.»
But the big financial push by Stanford raises startup culture to a new level, far exceeding the
impact of accelerator
programs and business plan competitions offered by most universities.
In recently commissioned research by Ryerson's Jim Pattison Ethical Leadership
program about the Ethics
of Political Leadership, some disturbing trends about the ethical
impact of the mayor's reign
of error have been highlighted.
Though earlier torpedoes would be
programmed to detonate upon
impacting or nearing the hull
of an enemy vessel, the Mark 48 takes a different path... literally.
That's why we introduced the Recreational Fisheries Conservation Partnerships
Program, which doubled the
impact of every dollar invested in its first year.
Amazon just made a big change to its affiliate
program, which could have an
impact on the incomes
of members ranging from YouTube stars to traditional media companies.
Of course, when the federal government and states make changes to hunger
programs, it has a direct and hard - hitting
impact on the groups that act as a safety net.
Unlike more casual
programs, formalized flexible work
programs help employers track the
impact of such arrangements, improve the benefits and reduce the pitfalls.
«Every single one
of the businesses [in the SheEO
program] is motivated by profound social
impact.»
Yet the
impact of the
program goes far beyond major institutions like MD Anderson.
«For all 12 business support
programs, no attempt has been made by the province to isolate the
impact of provincial support against what would have happened without provincial funding,» the report said.
In January, the
program graduates its inaugural class
of four teams, whose creations include a biosignal - tracking wristband; an
impact - monitorinwg mouthguard that can help athletes avoid aggravating head injuries; a tracking device for skateboards; and a robotic toy that teaches kids as young as 4 to code.
For all these reasons, and as both a corporate wellness executive and a doctor whose wellness center is deliberately located on a working farm — given its profound healing
impact, I find employee gardens to be the most exciting
of the new generation
of corporate wellness
programs.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange
impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Kaplan acknowledges that while we can't technically mistreat artificial intelligence
programs in the same way we are capable
of mistreating other people, how we treat AI
programs may
impact how we treat people.
«In order to accelerate meaningful corporate and market
impact, many corporations are expanding their CVC unit mandates to include traditional minority investments, majority equity investment more consistent with Growth PE, M&A and internal commercial piloting and incubation
programs; and compensation structures need to keep pace with these changes,» said Heidi Mason, managing partner
of Bell Mason Group and co-founder
of CVI ².
Check out this exhaustive list
of split testing options, and start testing to improve the
impact of your
programs.
The Comptroller General
of the United States (referred to in this section as the Comptroller General) shall conduct a study addressing the effectiveness and overall
impact of the following priority review voucher
programs, including any such
programs amended or established by this Act: